Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.24.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Accounts receivables and contract assets, allowance for credit losses $ 28 $ 21
Short-Term Debt, Fair Value 309  
Long-term debt fair value $ 0 $ 287
Series A    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 73,084,484 73,066,321
Common stock, shares outstanding 73,084,484 73,066,321
Series B    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 7,500,000 7,500,000
Common stock shares issued 4,232,532 4,057,532
Common stock, shares outstanding 4,232,532 4,057,532
Series C    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0